| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/22/1997 | US5622962 Prostate cancer, skin disorders, baldness |
| 04/22/1997 | US5622961 5α-reductase inhibitors |
| 04/22/1997 | US5622957 Inducers of tyrosine hydroxylase; treatment of depression and anxiety |
| 04/22/1997 | US5622951 Piperazine derivatives as 5-HT antagonists |
| 04/22/1997 | US5622946 Radiation sensitization using texaphyrins |
| 04/22/1997 | US5622941 Administering the dosage form, nontoxic activated vitamin d; sustain release, side-effect reducation |
| 04/22/1997 | US5622939 Glucan preparation |
| 04/22/1997 | US5622935 Medicine for preventing and curing bone fracture |
| 04/22/1997 | US5622932 IGF-1 superagonists |
| 04/22/1997 | US5622928 Glia activation factor and its production |
| 04/22/1997 | US5622927 Mixture containing folic acid, panthenol and/or allantoin, protein hydrolysate, lactose or dextrose, lactic acid, magnesium sulfate, sodium or ammonium chloride, and a carrier; stability |
| 04/22/1997 | US5622721 Dosage forms of risedronate |
| 04/22/1997 | US5622701 Provides monoclonal antibodies that have binding site that specifically binds to p-selectin and to e-selectin |
| 04/22/1997 | CA2029776C Selenophen derivatives, a preparation process of the same and therapeutical compositions containing them |
| 04/17/1997 | WO1997013787A1 Vegf-binding polypeptide |
| 04/17/1997 | WO1997013781A2 Synthetic peptides that inhibit il-6 activity |
| 04/17/1997 | WO1997013771A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/17/1997 | WO1997013768A1 Oxazolidin-2-one derivatives, preparation method therefor and therapeutical use thereof |
| 04/17/1997 | WO1997013751A1 Indole carbamates as leukotriene antagonists |
| 04/17/1997 | WO1997013512A1 N-[2-substituted-3-(2-aminoethyl)-1h-indol-5-yl]-amides: new 5-ht1f agonists |
| 04/17/1997 | WO1997013511A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | WO1997013505A2 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 04/17/1997 | WO1997013504A1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 04/17/1997 | WO1997005864A3 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs |
| 04/17/1997 | WO1997005862A3 Use of basic amino acids and derivatives for lowering ceramide levels |
| 04/17/1997 | CA2234404A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 04/17/1997 | CA2234166A1 N-¬2-substituted-3-(2-aminoethyl)-1h-indol-5-yl|-amides: new 5-ht1f agonists |
| 04/17/1997 | CA2231561A1 Use of a .gamma.-rar-specific agonist ligand to increase apoptosis rate |
| 04/17/1997 | CA2187850A1 Physiologically active ei-1941 compounds |
| 04/16/1997 | EP0768318A2 Peptide having collagen contraction inhibiting activity |
| 04/16/1997 | EP0768312A2 Bis-Staurosporine and K-252a derivatives |
| 04/16/1997 | EP0768309A1 Process for the preparation of enantiomerically pure imidazolyl compounds |
| 04/16/1997 | EP0768306A1 Physiologically active hydrogenated benzopyran compounds |
| 04/16/1997 | EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 04/16/1997 | EP0768301A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists |
| 04/16/1997 | EP0767840A2 Method for introducing foreign matter into higher eukaryotic cells |
| 04/16/1997 | EP0767835A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 04/16/1997 | EP0767800A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 04/16/1997 | EP0767794A1 Phosphinic acid derivatives |
| 04/16/1997 | EP0767793A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 04/16/1997 | EP0767792A1 Vitronectin receptor antagonists |
| 04/16/1997 | EP0767783A1 Substituted alkyldiamine derivatives and their use as tachykinin antagonists |
| 04/16/1997 | EP0767782A1 Aryl and heteroaryl alkoxynaphthalene derivatives |
| 04/16/1997 | EP0767777A1 New salts of 2- (2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations |
| 04/16/1997 | EP0767676A1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 04/16/1997 | EP0767673A1 Methods for reduced renal uptake of antibody fragments |
| 04/16/1997 | EP0767671A1 Method of combating acyclovir-resistant herpes simplex viral infections |
| 04/16/1997 | EP0767666A1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 04/16/1997 | EP0767664A2 Combination therapy for hiv infection |
| 04/16/1997 | EP0767661A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 04/16/1997 | EP0767658A1 Anti-acne cosmetic compositions |
| 04/16/1997 | EP0701551B1 3-(indol-3-yl) propenoic acid derivatives useful as nmda antagonists |
| 04/16/1997 | EP0656780B1 Drugs containing diphosphonic acids and salts thereof |
| 04/16/1997 | EP0651647B1 Glutathione as chemoprotective agent |
| 04/16/1997 | EP0586525B1 Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives |
| 04/16/1997 | EP0536282B1 Meducament for treating prostatic adenocarcinoma |
| 04/16/1997 | CN1147767A Use of serotonin antagonists (5HT3) for treating fibromyalgia |
| 04/16/1997 | CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/16/1997 | CN1147512A Substituted 4H-pyrans |
| 04/16/1997 | CN1147506A Benzoazepine-Benzooxaazepine-Benzothiaazepine-N-acetate derivant |
| 04/16/1997 | CN1147377A Penicillin menstruum for injection |
| 04/16/1997 | CN1034588C Improved method for man-promoting growth factor C |
| 04/16/1997 | CN1034577C Producing process for peptides having bradykinin-antagonistic action |
| 04/16/1997 | CN1034575C Producing process for selective adenosine receptor agents |
| 04/16/1997 | CN1034572C Cyclic anthranilicacid acetic acid derivatives and process for prepn. |
| 04/16/1997 | CN1034569C Endothelin receptor antagonists |
| 04/15/1997 | US5621117 Method for the racemization of enantiomers of α-lipoic acid |
| 04/15/1997 | US5621113 4-[(thien-2-yl)methyl]-imidazole analgesics |
| 04/15/1997 | US5621109 Retroviral protease inhibiting compounds |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621098 Process for preparing bis-indolyl macrocycles |
| 04/15/1997 | US5621081 Polypeptide; treatment of nervous system disorders |
| 04/15/1997 | US5621009 Chondroprotective agents |
| 04/15/1997 | US5621002 Having a modified competitive enzyme activity inhbitor linked to a spacer-drug; enzyme cleavage at a lower concentration, i.e. low michaelis-menten constant(km) |
| 04/15/1997 | US5620996 Sulfonamidocarbonyl pyridine-2-carboxesteramides and their pyridine-N-oxide compounds and their use as pharmaceuticals |
| 04/15/1997 | US5620995 Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals |
| 04/15/1997 | US5620992 Having 5-hydroxytryptamine receptor antagonist activity |
| 04/15/1997 | US5620991 Aromatic amidine derivatives and salts thereof |
| 04/15/1997 | US5620990 Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol esters, their preparation and their therapeutic application |
| 04/15/1997 | US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
| 04/15/1997 | US5620988 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 04/15/1997 | US5620987 Amino acid derivatives |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620978 Nervous system disorders |
| 04/15/1997 | US5620976 Benzoxazine derivatives |
| 04/15/1997 | US5620966 11,21-bisphenyl-19-norpregnane derivatives |
| 04/15/1997 | US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/15/1997 | US5620867 Isolated dna molecule comprising nucelotide sequence encoding polypeptide having specified amino acid sequence |
| 04/15/1997 | CA2110410C Therapeutic compositions for osteoinduction |
| 04/15/1997 | CA2104229C Opiate receptor antagonist modulates movement disorder |
| 04/12/1997 | CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists |
| 04/10/1997 | WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
| 04/10/1997 | WO1997012978A1 NOVEL c-mpl RECEPTOR AGONISTS |
| 04/10/1997 | WO1997012963A2 A paf-acetylhydrolase and use in therapy |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012888A1 Purine and guanine derivatives |
| 04/10/1997 | WO1997012887A1 Purine and guanine derivatives as pnp inhibitors |
| 04/10/1997 | WO1997012876A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/10/1997 | WO1997012867A1 SYMMETRICAL bis-HETEROARYLMETHOXYPHENYLALKYL CARBOXYLATES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |